KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Long-Term Deferred Tax (2016 - 2020)

Historic Long-Term Deferred Tax for Emergent BioSolutions (EBS) over the last 12 years, with Q1 2020 value amounting to $17.6 million.

  • Emergent BioSolutions' Long-Term Deferred Tax changed N/A to $17.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was $17.6 million, marking a year-over-year change of. This contributed to the annual value of $13.4 million for FY2019, which is 0.0% changed from last year.
  • Emergent BioSolutions' Long-Term Deferred Tax amounted to $17.6 million in Q1 2020.
  • Over the past 5 years, Emergent BioSolutions' Long-Term Deferred Tax peaked at $18.2 million during Q2 2016, and registered a low of $2.8 million during Q4 2017.
  • Over the past 5 years, Emergent BioSolutions' median Long-Term Deferred Tax value was $12.0 million (recorded in 2016), while the average stood at $10.5 million.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first plummeted by 7239.45% in 2017, then skyrocketed by 37857.14% in 2018.
  • Over the past 5 years, Emergent BioSolutions' Long-Term Deferred Tax (Quarter) stood at $6.1 million in 2016, then tumbled by 54.07% to $2.8 million in 2017, then soared by 378.57% to $13.4 million in 2018, then changed by 0.0% to $13.4 million in 2019, then surged by 31.34% to $17.6 million in 2020.
  • Its Long-Term Deferred Tax stands at $17.6 million for Q1 2020, versus $13.4 million for Q4 2019 and $13.4 million for Q4 2018.